The drugmaker’s shares tumbled in Copenhagen after saying a fifth of users discontinued its weight-loss drug because of gastrointestinal issues.
Zealand Pharma loses a fifth of its value as many users gave up taking weight-loss drug during trial
Related Posts
Popular News
Latest News
Zcash founder outlines two-step response to critical Orchard vulnerability
Josh Swihart has detailed Zcash’s emergency response to a vulnerability that could have enabled unlimited counterfeit ZEC creation, as the...
Intesa launches $35 billion Monte dei Paschi bid in record Italian banking deal
Intesa launches $35 billion Monte dei Paschi bid in record Italian banking deal
Zealand Pharma loses a fifth of its value as many users gave up taking weight-loss drug during trial
The drugmaker’s shares tumbled in Copenhagen after saying a fifth of users discontinued its weight-loss drug because of gastrointestinal issues.
How Likely Was Zcash Exploited? Grayscale CLO Answers
Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure Grayscale Chief Legal Officer Craig Salm has...
Welcome to Global Finances Daily, your go-to source for all things finance. Our mission is to provide our readers with valuable information and insights to help them achieve their financial goals and secure their financial future.